The Effect of Inspiratory Muscle Training and Breathing Exercises Combined With Upper Extremity and Trunk in Patients With Sarcoidosis
The Effect of Inspiratory Muscle Training and Breathing Exercises Combined With Upper Extremity and Trunk in Patients With Sarcoidosis
This is an educational work. Thirty patients with pulmonary sarcoidosis will be included in
 the study and randomly selected into two training groups.One group will receive home
 inspiratory muscle training (IMT) for 15 minutes, twice a day, 7 days a week with the resh
 Threshold IMT 'device. In the IMT group, the initial training intensity will be determined by
 measuring the maximal inspiratory muscle strength (MIP) with the intraoral pressure measuring
 device, 30% of the measured (MIP) value will be started at the first evaluation and the new
 training intensity will be determined by calculating 30% of the measured value by repeating
 the MIP measurement every week. The other group will perform upper extremity and trunk
 exercises combined with respiratory exercises at home for 7 days, twice a day for 15
 minutes.Patients will be evaluated before the training program and 8 weeks after the
 training. In the first evaluation, demographic information and clinical characteristics of
 the patients will be noted.In this study, upper and lower extremity exercise capacity,
 respiratory functions, peripheral muscle strength, dyspnea, fatigue, sleep quality, cognitive
 function, daily living activities, physical activity level, anxiety, depression, upper
 extremity and trunk exercises combined with inspiratory muscle training in patients with
 sarcoidosis and the impact on quality of life.
Patients who are in stage II-III with sarcoidosis diagnosed pulmonary involvement who are
 admitted to the Department of Chest Diseases of Cerrahpaşa Medical Faculty Hospital of
 Istanbul University will be included in the 30-70 age group 6 months after systemic treatment
 or no treatment. Patients with stages I and IV, malignancy, heart failure, orthopedic
 problems and who have to undergo systemic sarcoidosis treatment during the study will not be
 included in the study. Thirty-four patients who meet the inclusion criteria will be included
 in the study by signing the informed consent form. In the first evaluation, demographic
 information and clinical characteristics of the patients will be noted. Lower and upper
 extremity functional capacities of the patients before and after training will be evaluated
 with 6-minute walk test (6MWT), 6-minute step test (6DST), 6-minute pegboard ring test
 (6DPBRT) and 30-second sit-down test. Percentage values of FVC, FEV1, FEV1 / FVC, PEF, FEF
 (25-75%) parameters according to measured and expected values will be recorded by performing
 pulmonary function test. Respiratory muscle strength will be determined by measuring maximal
 inspiratory pressure (MRP) and maximal expiratory pressure (MEP) with the intraoral pressure
 gauge. Dyspnea sensation Modified Borg and Modified Medical Research Council (MMRC) scale,
 fatigue state Fatigue Severity Scale (FSS), peripheral muscle strength hand dynamometer,
 quality of life George Respiratory Diseases Questionnaire (SGRQ), anxiety and depression
 status Hospital Anxiety and Depression Scale (HAD), physical activity level International
 Physical Activity Questionnaire-Short form (IPAQ-S), cognitive function Montreal Cognitive
 Assessment Scale (MOCA), daily living activities London Chest Daily Living Activities Scale
 and sleep quality will be evaluated with Epworth Sleepiness Scale (ESS).
Inclusion Criteria:

 -  The study was conducted in Istanbul University Cerrahpaşa Medical Faculty Hospital
 Pulmonary Diseases Department with sarcoidosis diagnosed with pulmonary involvement in
 stage II-III,

 -  6 months after receiving systemic treatment or no treatment.

 Exclusion Criteria:

 -  Patients with stage I and IV,

 -  malignancy,

 -  heart failure,

 -  orthopedic problems

 -  who had to undergo systemic sarcoidosis treatment during the study